Cyclooxygenase-2 Inhibitor Enhances Whereas Prostaglandin E2Inhibits the Production of Interferon-Induced Protein of 10 kDa in Epidermoid Carcinoma A431-Reference-Cited by-同舟云学术

Cyclooxygenase-2 Inhibitor Enhances Whereas Prostaglandin E2Inhibits the Production of Interferon-Induced Protein of 10 kDa in Epidermoid Carcinoma A431

Published:2002-11 Issue:5 Volume:119 Page:1080-1089
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Kanda Naoko,Watanabe Shinichi

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference51 articles.

1. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels;Anastassiou;J Immunol,1992

2. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases;Arenberg;J Exp Med,1996

3. Prostaglandin E receptors in myometrial cells;Asboth;Acta Physiol Hung,1997

4. Co-expression of prostaglandin receptors with opposite effects;Ashby;Biochem Pharmacol,1998

5. Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses;Bluyssen;Proc Natl Acad Sci USA,1995

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multilevel pharmacological manipulation of adenosine–prostaglandin E2/cAMP nexus in the tumor microenvironment: A ‘two hit’ therapeutic opportunity;Pharmacological Research;2013-07

2. Selected ebselen analogs reduce mechlorethamine toxicityin vitro;Cutaneous and Ocular Toxicology;2013-06-04

3. Ebselen Reduces the Toxicity of Mechlorethamine in A-431 Cells via Inhibition of Apoptosis;Journal of Biochemical and Molecular Toxicology;2013-05-06

4. Ebselen Analogues Reduce 2-chloroethyl Ethyl Sulphide Toxicity in A-431 Cells;Archives of Industrial Hygiene and Toxicology;2013-03-01

5. Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer;Breast Cancer Research;2012-02